Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Carbamazepine Dosing
Clinical guideline published by Clinical Pharmacogenetics Implementation Consortium (CPIC) on
The Clinical Pharmacogenetics Implementation Consortium (CPIC) is an international group dedicated to enhancing the use of pharmacogenetic testing in clinical settings. They develop and share peer-reviewed, evidence-based guidelines to aid healthcare providers in making informed prescribing decisions based on genetic test results.